已收盤 02-06 16:00:00 美东时间
+0.130
+1.22%
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
RBC Capital analyst Matthew Hedberg downgrades EverCommerce (NASDAQ:EVCM) from Outperform to Sector Perform and maintains the price target from $12 to $12.
01-06 00:37
KYTX大涨超23%,Miv-cel临床试验取得积极成果;IMNM涨近16%,实验性药物晚期临床试验达主要终点;以星航运涨近9%,获瑞士航运集团收购要约>>
2025-12-16 19:53
EverCommerce Inc.'s CEO Eric Remer and SVP Brad Korch will present and attend 1x1 meetings at the 2025 RBC Capital Markets Conference in New York on November 18, 2025. The company provides SaaS solutions for over 725,000 service-based businesses, offering tools for growth, operational efficiency, and customer retention through its EverPro, EverHealth, and EverWell brands.
2025-11-17 13:00
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
2025-11-11 10:49
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
2025-11-10 10:22
Earnings Call Insights: EverCommerce Inc. (EVCM) Q3 2025 Management View Eric Remer, Founder, Chairman & CEO, announced "EverCommerce generated revenue of $147.5 million within the previously provided...
2025-11-08 05:16
RBC Capital analyst Matthew Hedberg maintains EverCommerce (NASDAQ:EVCM) with a Outperform and lowers the price target from $13 to $12.
2025-11-08 02:59
EverCommerce (NASDAQ:EVCM) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. This is a 160 percent increase over losses of $(0.05) per share from the same period last year. The
2025-11-07 08:17